Ren, M., Qin, H., Ren, R., & Cowell, J. K. (2012). Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities.
Chicago Stili AlıntıRen, Mingqiang, Haiyan Qin, Ruizhe Ren, ve John K. Cowell. Ponatinib Suppresses the Development of Myeloid and Lymphoid Malignancies Associated With FGFR1 Abnormalities. 2012.
MLA AlıntıRen, Mingqiang, Haiyan Qin, Ruizhe Ren, ve John K. Cowell. Ponatinib Suppresses the Development of Myeloid and Lymphoid Malignancies Associated With FGFR1 Abnormalities. 2012.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..